TABLE 2.
Oligonucleotide | Orientationa | Locationb | Sequence (5′ → 3′)c | CMV sequence(s) amplified |
---|---|---|---|---|
DNA polymerase degenerate primers | ||||
CMV1F1 | + | 721–749 | GAC AAG AAG TTG ACN ACN TTY GGN TGG TG | AmacCMV1, AsenCMV1, ApanCMV1 |
CMV1R1 | − | 1534–1559 | ACG CCG GCY TCR TAR TGR AAR TTD AT | AmacCMV1, AsenCMV1, ApanCMV1 |
CMV1R2 | − | 1480–1504 | CGT CCT GHA CRC ART AYT TNC CNA C | AmacCMV1, AsenCMV1, ApanCMV1 |
CMV2F1 | + | 1330–1352 | GAY ATG TAY CCN GTS TGY ATG GC | AmacCMV1, AsenCMV1, ApanCMV1, PpitCMV1, SapeCMV1, SalbCMV1 |
CMV2F2 | + | 1372–1394 | TAC AAR YTV AAY ACB ATG GCS GA | AmacCMV1, AsenCMV1, ApanCMV1, PpitCMV1, SapeCMV1, SalbCMV1 |
DFASAd | + | 1768–1793 | GTG TTC GAC TTY GCN AGY YTN TAY CC | All |
CMV3F1 | + | 1795–1817 | TCH ATY ATY ATG GCN CAY AAY CT | All |
CMV3F2 | + | 2062–2090 | ACG TGC AAT TCT TTY TAY GGB TTY ACN GG | All |
CMV3R1 | − | 2269–2303 | CGA TAG CAC ACA AAC ACR CTR TCN GTR TCN CCR TA | All |
CMV3R2 | − | 2125–2147 | CCG ATD CGN GTR ATR CTR GCC GC | All |
CMV4F1 | + | 2266–2291 | ATC TAY GGK GAC ACS GAY AGY GTS TT | AmacCMV1, AsenCMV1, ApalCMV1, AnanCMV1, ApanCMV1 |
CMV4R1 | − | 2782–2801 | GCC GCY ARN CGY TTD ATG AC | ApalCMV1, AnanCMV1, ApanCMV1 |
CMV4R2 | − | 2477–2498 | CGC ACC ARR TCR ACN CCY TTC A | AmacCMV1, AsenCMV1, ApalCMV1, AnanCMV1, ApanCMV1 |
CMV4R3 | − | 2419–2444 | ATA TAC CGY TTY TTR CAG ATC ATC AT | AmacCMV1, AsenCMV1, ApalCMV1, AnanCMV1, ApanCMV1 |
DNA polymerase antisense specific primers (in combination with CMV2F1 or CMV2F2)e | ||||
PitR1 | − | 1958–1978 | TGC GCT GAG CAA CCC ATT TAG | PpitCMV1 |
PitR2 | − | 1912–1932 | ACG CAC CTC CGA CTT CAC AAA | PpitCMV1 |
AotR1 | − | 2019–2039 | TTG TCG AGC AGC GTC CTC TTG | AnanCMV1, AvocCMV1 |
AotR2 | − | 1884–1904 | ACC GTA CCG TTT TCG AAG TTA | AnanCMV1, AvocCMV1 |
SapR1 | − | 2106–2126 | GCG ACT GGC AAA CAC GGT AAC | SapeCMV1 |
CapR2 | − | 1994–2016 | GGG ATC TGT GCA ATC TTT CAT GG | CalbCMV1, CcapCMV1 |
CapR3 | − | 1939–1961 | CGG GTC AAC AAT TCA GAA AGC AC | SapeCMV1, CalbCMV1, CcapCMV1 |
AteR1 | − | 1994–2016 | CGG ATC TCT GCA ATT TTT CAT GG | ApanCMV1 |
AteR2 | − | 1935–1957 | TCA GCA GTT CGG ACA ACA CTG AA | ApanCMV1 |
SaiR1 | − | 1948–1969 | CCA CCC ACT TCG TTA GCA GCT C | SbolCMV1, SalbCMV1 |
SaiR2 | − | 2155–2175 | ACG CGC GGT GTC TTG TAA CAT | SbolCMV1, SalbCMV1 |
AloR1 | − | 1959–1979 | TTC CGT TGA GCC ACC CAT TTA | AmacCMV1, AsenCMV1, ApalCMV1 |
AloR2 | − | 1932–1954 | GCA ATT CCG ATA GCA CTG AGG AA | AmacCMV1, AsenCMV1, ApalCMV1 |
+, sense; −, antisense.
Positions relative to ATG of the DNA polymerase gene of AoHV1 (accession number FJ483970).
Letters at positions of degeneracy follow the International Unit Base codes.
Degenerate oligonucleotide primer described by Rose et al. (46).
For clarity, all antisense specific primers are indicated as XxxR1 for R1 primers and XxxR2 for R2 primers in Fig. 2.